Domestically Produced, Globally Certified Solution for Nutritional Fat Emulsions
【GUANGZHOU, CHINA】– 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical excipients and active pharmaceutical ingredients (APIs), today announced the launch of its injectable soybean oil, a critical raw material for nutritional fat emulsions. This domestically manufactured product addresses long-standing supply chain gaps for pharmaceutical manufacturers, offering a reliable alternative to imported equivalents with stable supply, global regulatory compliance, and strict quality control. The product is now available for global pre-orders, with full-scale production and shipping starting immediately .
Core Technical Breakthroughs & Product Highlights
Domestic Supply Security
As part of its efforts to break foreign monopolies in high-end pharmaceutical excipients, Guangzhou Hanfang has increased the localization rate of injectable lipid excipients from 10% to 90%, ensuring a stable and uninterrupted supply for global pharmaceutical manufacturers. This eliminates reliance on imported raw materials, reducing supply chain risks and cost volatility .
Green Manufacturing Technology
The injectable soybean oil is produced using an integrated green technology combining supercritical CO₂ extraction, membrane separation, and chromatographic separation, replacing traditional polluting processes. This technology ensures high purity and consistency of the product while minimizing environmental impact .
Strict Quality Standards
Designed as an energy supplement and pharmaceutical excipient, the product meets the rigorous requirements of high-end injectable manufacturers, providing a safe and effective raw material for nutritional fat emulsions. Each batch undergoes strict quality control to ensure compliance with global pharmaceutical standards .
Global Compliance & Certifications
To meet global market access requirements, Guangzhou Hanfang’s injectable soybean oil has obtained multiple international certifications, including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. The company also holds national-level qualifications such as being a National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise, reinforcing its authority and credibility in the global pharmaceutical industry .
Supply Information & Customized Services
The injectable soybean oil is now available for pre-order through the official website (http://byshanhanfang.com/) and global authorized distributors, with full-scale production and shipping starting immediately. In addition to standard products, Guangzhou Hanfang offers customized processing services to meet the diverse needs of pharmaceutical and functional food manufacturers worldwide .
Authoritative Quotes
"The launch of our injectable soybean oil marks a significant step in our mission to achieve technological self-reliance and address bottleneck technologies in the pharmaceutical industry. This product not only ensures stable supply for domestic and global manufacturers but also upholds the highest international quality standards," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited. "We will continue to innovate to support the global pharmaceutical supply chain security and meet the evolving needs of our clients" .
Industry Background & Corporate Strategy
Against the backdrop of growing global demand for high-end pharmaceutical excipients driven by the expansion of advanced drug formulations, Guangzhou Hanfang’s launch of injectable soybean oil addresses critical supply chain challenges. This move aligns with the company’s strategy to become a global leader in pharmaceutical lipid excipients, leveraging its R&D capabilities and manufacturing strength to serve global clients .
Future Plans
Looking ahead, Guangzhou Hanfang Pharmaceutical Company Limited will continue to deepen its focus on high-end pharmaceutical lipid excipients, increasing R&D investment to launch more innovative products. The company will also expand its global sales and service network to provide localized support for clients in more countries and regions .
About Guangzhou Hanfang Pharmaceutical Company Limited
Founded in 1998, Guangzhou Hanfang Pharmaceutical Company Limited is a state-owned high-tech enterprise under Guangzhou Pharmaceutical Holdings (GPHL), specializing in high-end pharmaceutical lipid excipients, oncology APIs, and Ganoderma health products. Headquartered in Guangzhou, China, the company operates a sole production base in Conghua, with R&D centers in Haizhu and Zhuhai Hengqin. It holds over 240 patents, serves more than 1,000 clients across 30+ countries and regions (including B. Braun and AstraZeneca), and has obtained multiple global certifications. The company’s mission is to achieve technological self-reliance, break bottleneck technologies, and safeguard pharmaceutical supply chain security .
Contact Information
Company: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/
Copyright Information
© 2026 Guangzhou Hanfang Pharmaceutical Company Limited. All rights reserved.
